Spinal Cord Series and Cases, 2018 · DOI: https://doi.org/10.1038/s41394-018-0096-1 · Published: June 7, 2018
Cannabis has been shown to be an effective treatment for pain, particularly for individuals with spinal cord injuries. Despite this, political and historical factors have limited its availability for both patients and researchers. The classification of cannabis as a Schedule I drug, indicating no medical value and high abuse risk, is based on politically driven international conventions rather than scientific evidence. There is a conflict between protecting society and allowing individuals with chronic pain the right to effective treatment, especially when current medications have limitations and risks.
Reclassifying cannabis to reflect its medicinal value and reduce restrictions on research and access.
Encouraging open dialogue between patients and physicians regarding cannabis use for pain management, supported by accurate information.
Considering access to cannabis for medical purposes as a human rights issue, ensuring patients' dignity and respect.